📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Lumen Bioscience

1.1 - Company Overview

Lumen Bioscience Logo

Lumen Bioscience

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biologic drug and vaccine development and manufacturing, leveraging a platform for rapid, cost-effective production. Pipeline includes biologic cocktails for C. difficile colitis, Covid-19 GI infection, and inflammatory bowel disease, a preclinical cardiometabolic program with Novo Nordisk, and a Phase 2 product candidate for traveler’s diarrhea backed by CARB-X and the Bill & Melinda Gates Foundation.

Products and services

  • Biologic Drugs Development and Manufacturing: Lumen Bioscience discovers, develops, and produces biologic drugs and vaccine candidates using a platform-based technology enabling rapid and cost-effective production across multiple diseases
  • Traveler’s Diarrhea Treatment: A Phase 2-stage product candidate treating traveler’s diarrhea from C. jejuni and E. coli, backed by CARB-X and Bill & Melinda Gates Foundation, using a biologic cocktail
  • C. difficile Colitis Treatment: A cocktail-based product candidate targeting C. difficile colitis, utilizing multiple biologics for both treatment and prevention.

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Lumen Bioscience

Nucleonics Logo

Nucleonics

HQ: United States Website
  • Description: Provider of RNA interference-based therapeutics as a biotechnology company.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Nucleonics company profile →
Ibis Biosciences Logo

Ibis Biosciences

HQ: United States Website
  • Description: Provider of products for the identification and characterization of infectious agents, including the Ibis T5000 Biosensor System, a hardware platform that identifies biological organisms such as bacteria, viruses, fungi and protozoa and provides information on drug resistance.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Ibis Biosciences company profile →
Micronics Logo

Micronics

HQ: United States Website
  • Description: Provider of near-patient in vitro diagnostic products for disease diagnosis, prognosis, and treatment monitoring in the United States and internationally, including the PanNAT molecular diagnostic system, a point-of-care testing instrument.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Micronics company profile →
HilleVax Logo

HilleVax

HQ: United States Website
  • Description: Provider of novel vaccine development and commercialization, focused on HIL-214, a bivalent GI.1/GII.4 virus-like particle (VLP) vaccine candidate in development to prevent moderate-to-severe acute gastroenteritis caused by norovirus infection.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full HilleVax company profile →
Altesa BioSciences Logo

Altesa BioSciences

HQ: United States Website
  • Description: Provider of clinical-stage biopharmaceutical research and development focused on accelerating the development of new treatments.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Altesa BioSciences company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Lumen Bioscience

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Lumen Bioscience

2.2 - Growth funds investing in similar companies to Lumen Bioscience

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Lumen Bioscience

4.2 - Public trading comparable groups for Lumen Bioscience

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Lumen Bioscience

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Lumen Bioscience

What does Lumen Bioscience do?

Lumen Bioscience is a provider of biologic drug and vaccine development and manufacturing, leveraging a platform for rapid, cost-effective production. Pipeline includes biologic cocktails for C. difficile colitis, Covid-19 GI infection, and inflammatory bowel disease, a preclinical cardiometabolic program with Novo Nordisk, and a Phase 2 product candidate for traveler’s diarrhea backed by CARB-X and the Bill & Melinda Gates Foundation.

Who are Lumen Bioscience's competitors?

Lumen Bioscience's competitors and similar companies include Nucleonics, Ibis Biosciences, Micronics, HilleVax, and Altesa BioSciences.

Where is Lumen Bioscience headquartered?

Lumen Bioscience is headquartered in United States.

How many employees does Lumen Bioscience have?

Lumen Bioscience has 1,000 employees 🔒.

When was Lumen Bioscience founded?

Lumen Bioscience was founded in 2010 🔒.

What sector and industry vertical is Lumen Bioscience in?

Lumen Bioscience is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Lumen Bioscience

Who are the top strategic acquirers in Lumen Bioscience's sector and industry

Top strategic M&A buyers and acquirers in Lumen Bioscience's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Lumen Bioscience?

Top strategic M&A buyers groups and sectors for Lumen Bioscience include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Lumen Bioscience's sector and industry vertical

Which are the top PE firms investing in Lumen Bioscience's sector and industry vertical?

Top PE firms investing in Lumen Bioscience's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Lumen Bioscience's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Lumen Bioscience's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Lumen Bioscience's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Lumen Bioscience include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Lumen Bioscience's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Lumen Bioscience?

The key public trading comparables and valuation benchmarks for Lumen Bioscience include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Lumen Bioscience for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Lumen Bioscience with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Lumen Bioscience's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Lumen Bioscience with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Lumen Bioscience's' sector and industry vertical?

Access recent funding rounds and capital raises in Lumen Bioscience's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Lumen Bioscience